SEARCH

SEARCH BY CITATION

References

  • 1
    Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26: 62S65S.
  • 2
    Committee on Infectious Diseases, American Academy of Pediatrics. Hepatitis C virus infection. Pediatr 1998; 101: 481485.
  • 3
    Bortolotti F, Resti M, Giacchino R, Crivellaro C, Zancan L, Azzari C, Gussetti N, et al. Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. J Pediatr 1998; 133: 378381.
  • 4
    Alter MJ, Kruszon-Moran D, Najnan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556562.
  • 5
    Resti M, Azzari C, Rossi ME, Vullo C, Zammarchi E, Vierucci A. Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A, non-B hepatitis. Eur J Pediatr 1992; 151: 573576.
  • 6
    Lai ME, DeVirgilis S, Argiolu F, Farci P, Mazzoleni AP, Lisci V, Rapicetta M, et al. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of postransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay. J Pediatr Gastroenterol Nutr 1993; 16: 458464.
  • 7
    Blanchette VS, Vorstmann E, Shore A, Wang E, Petric M, Jett BW, Alter HJ. Hepatitis C infection in children with hemophilia A and B. Blood 1991; 78: 285289.
  • 8
    Locasciulli A, Gornati G, Tagger A, Ribero ML, Cavalleto D, Masera G, Shulman HM, et al. Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood 1991; 78: 16191622.
  • 9
    Rossetti F, Cesaro S, Pizzocchero P, Cadrobbi P, Guido M, Zanesco L. Chronic hepatitis B surface antigen-negative hepatitis after treatment of malignancy. J Pediatr 1992; 121: 3943.
  • 10
    Ni Y-H, Chang M-H, Lue H-C, Hsu H-Y, Wang M-J, Chen P-J, Chen D-S. Posttransfusion hepatitis C virus infection in children. J Pediatr 1994; 124: 709713.
  • 11
    Jonas MM, Zilleruelo GE, LaRue SI, Abitbol C, Strauss J, Lu Y. Hepatitis C in a pediatric dialysis population. Pediatrics 1992; 89: 707709.
  • 12
    Greco M, Cristiano K, Leozappa G, Rapicetta M, Rizzoni G. Hepatitis C infection in children and adolescents on haemodialysis and after renal transplant. Pediatr Nephrol 1993; 7: 424427.
  • 13
    Tanaka E, Kiyosawa K, Soeyama T, Hayata T, Ohike Y, Nakano Y, Yoshizawa K, et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors. Am J Trop Med Hyg 1992; 46: 460464.
  • 14
    Lee S-D, Chan C-Y, Wnag Y-J, Wu J-C, Lai K-H, Tsai Y-T, Lo K-J. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1991; 13: 830833.
  • 15
    Khalifa AS, Mitchell BS, Watts DM, el-Samahy MH, el-Sayed MH, Hassan NF, Jennings GB, et al. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children. Am J Trop Med Hyg 1993; 49: 316321.
  • 16
    Gessoni G, Manoni F. Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: a seroepidemiological study. Eur J Med 1993; 2: 7982.
  • 17
    al-Faleh FZ, Ayoola EA, al-Jeffry M, al-Rashed R, al-Mofarreh M, Arif M, Ramia S, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology 1991; 14: 215218.
  • 18
    Ngatchu T, Stroffolini T, Rapicetta M, Chionne P, Lantum D, Chiaramonte M. Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon. J Trop Med Hyg 1992; 95: 5761.
  • 19
    Jonas MM, Robertson LM, Middleman AB. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr 1997; 131: 314316.
  • 20
    Pramoolsinsap C, Kurathong S, Lerdverasirikul P. Prevalence of anti-HCV antibody in family members of anti-HCV-positive patients with acute and chronic liver disease. SE Asian J Trop Med Pub Hlth 1992; 23: 1216.
  • 21
    Chang TT, Liou TC, Young KC, Lin XZ, Lin CY, Shin JS, Wu HL. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 1994; 42: 9196.
  • 22
    Camarero C, Martos I, Delgado R, Suarez L, Escobar H, Mateos M. Horizontal transmission of hepatitis C virus in households of infected children. J Pediatr 1993; 123: 9899.
  • 23
    Vegnente A, Iorio R, Saviano A, Fariello I, Aponte S, Nasca MG, Pensati P. Lack of intrafamilial transmission of hepatitis C virus in family members of children with chronic hepatitis C infection. Pediatr Infect Dis J 1994; 13: 886889.
  • 24
    American Academy of Pediatrics, Hepatitis C. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 1997; 99: 260264.
  • 25
    Hsu S-C, Chang M-H, Chen D-S, Hsu HC, Lee CY. Non-A, non-B hepatitis in children: a clinical, histologic, and serologic study. J Med Virol 1991; 35: 16.
  • 26
    Bortolotti F, Vajro P, Cadrobbi P, Lepore L, Zancan L, Barbera C, Crivellaro C, et al. Cryptogenic chronic liver disease and hepatitis C virus infection in children. J Hepatol 1992; 15: 7376.
  • 27
    Bortolotti F, Vajro P, Barbera C, Giacchino R, Cadrobbi P, Zancan L, Nebbia G, et al. Hepatitis C in childhood: epidemiological and clinical aspects. Bone Marrow Transplant 1993; 12 (Suppl): s21s23.
  • 28
    Bortolotti F, Jara P, Diaz C, Vajro P, Hierro L, Giacchino R, de la Vega A, et al. Posttransfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr 1994; 18: 279283.
  • 29
    Jonas MM, Ott MJ, Nelson SP, Badizadegan K, Perez-Atayde AR. Interferon-alpha treatment of chronic hepatitis C virus infection in children. Pediatr Infect Dis J 1998; 17: 241246.
  • 30
    Bortolotti F, Resti M, Giacchino R, Azzari C, Gussetti N, Crivellaro C, Barbera C, et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr 1997; 130: 990993.
  • 31
    Bortolotti F, Vajro P, Balli F, Giacchino R, Crivellaro C, Barbera C, Cataleta M, et al. Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol 1996; 25: 614620.
  • 32
    Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A, Wiebecke B, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341: 866870.
  • 33
    Matsuoka S, Tatara K, Hayabuchi Y, Nii M, Mori K, Kuroda Y. Posttransfusion chronic hepatitis C in children. J Paediatr Child Health 1994; 30: 544546.
  • 34
    Matsuoka S, Tatara K, Hayabuchi Y, Taguchi Y, Mori K, Honda H, Itou S, et al. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion. Pediatrics 1994; 94: 919922.
  • 35
    Aricò M, Maggiore G, Silini E, Bono F, Viganö C, Cerino A, Mondelli MU. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994; 84: 29192921.
  • 36
    Locasciulli A, Testa M, Pontisso P, Benvegnù L, Fraschini D. Corbetta A, Noventa F, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997; 90: 46284633.
  • 37
    Strickland DK, Riely CA, Patrick CC, Jones-Wallace D, Boyett JM, Waters B, Fleckenstein JF, et al. Hepatitis C infection among survivors of childhood cancer. Blood 2000; 95: 30653070.
  • 38
    Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, et al. Effect of iron overload on the response to recombinant interferon alpha treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 1994; 125: 123128.
  • 39
    Makris M, Preston FE, Rosendaal FR. The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 1996; 94: 746752.
  • 40
    Kage M, Fujisawa T, Shiraki K, Tanaka T, Fujisawa T, Kimura A, Shimamatsu K, et al. Pathology of chronic hepatitis C in children. Hepatology 1997; 26: 771775.
  • 41
    Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998; 28: 14161423.
  • 42
    Guido M, Rugge M, Jara P, Hierro L, Giacchino R, Larrauri J, Marino CE, et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology 1998; 115: 15251529.
  • 43
    Jonas MM. Treatment of chronic hepatitis C in pediatric patients. Clin Liver Dis 1999; 4: 855867.
  • 44
    Fujisawa T, Inui A, Ohkawa T, Komatsu H, Miyakawa Y, Onoue M. Response to interferon therapy in children with chronic hepatitis C. J Pediatr 1995; 127: 660662.
  • 45
    Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, Nebbia G, et al. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology 1995; 22: 16231627.
  • 46
    Iorio R, Pensati P, Porzio S, Fariello I, Guida S, Vegnente A. Lymphoblastoid interferon alfa treatment in chronic hepatitis C. Arch Dis Child 1996; 74: 152156.
  • 47
    Komatsu H, Fujisawa T, Inui A, Miyakawa Y, Onoue M, Sekine I, Hanada R, et al. Efficacy of interferon in treating chronic hepatitis C in children with a history of acute leukemia. Blood 1996; 87: 40724075.
  • 48
    Zwiener RJ, Fielman BA, Cochran C, Rogers BB, Dawson DB. Interferonalpha-2b treatment of chronic hepatitis C in children with hemophilia. Pediatr Infect Dis J 1996; 15: 906908.
  • 49
    Matsuoka S, Mori K, Nakano O, Yuasa Y, Taguchi Y, Hayabuchi Y, Kuroda Y. Efficacy of interferons in treating children with chronic hepatitis C. Eur J Pediatr 1997; 156: 704708.
  • 50
    Marcellini M, Kondili LA, Comparcola D, Spada E, Sartorelli MR, Palumbo M, Rapicetta M. High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease. Pediatr Infect Dis J 1997; 16: 10491053.
  • 51
    Di Marco V, Lo Iacono O, Almasio P, Ciaccio C, Capra M, Rizzo M, Malizia R, et al. Long-term efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C. Blood 1997; 90: 22072212.
  • 52
    Jacobson KR, Murray K, Zellos A, Schwarz KB. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2002; 34: 5258.
  • 53
    Bunn S, Kelly D, Murray KF, Shelton M, Olson A, Mieli-Vergani G, Zambas D, et al. Safety, efficacy and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic hepatitis C [Abstract]. Hepatology 2000; 32: 350A.
  • 54
    Comanor L, Minor J, Conjeevaram HS, Roberts EA, Alvarez F, Bern EM, Goyens P, et al. Impact of chronic hepatitis B and interferon-alfa therapy on growth of children. J Viral Hepatol 2001; 8: 139147.
  • 55
    Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, MacDonald D, Folkman J, Ezekowtiz RAB. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998; 132: 527530.
  • 56
    Miller VS, Zweiner RJ, Fielman BA. Interferon-associated refractory status epilepticus. Pediatrics 1994; 93: 511512.